Reply [2]

dc.authorscopusid7003369853
dc.contributor.authorMemis D.
dc.date.accessioned2024-06-12T10:29:12Z
dc.date.available2024-06-12T10:29:12Z
dc.date.issued2006
dc.description.abstract[No abstract available]en_US
dc.identifier.issn1590-8577
dc.identifier.issue3en_US
dc.identifier.scopus2-s2.0-33646562818en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage323en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/17636
dc.identifier.volume7en_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.relation.ispartofJournal of the Pancreasen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAcute Necrotizing; Anti-Inflammatory Agents; Comment; Indomethacin/Adverse Effects; Non-Steroidal; Pancreatitisen_US
dc.subjectIndometacin; Nonsteroid Antiinflammatory Agent; Abdominal Pain; Anamnesis; Drug Induced Disease; Drug Substitution; Drug Use; Drug Withdrawal; Human; Incidence; Letter; Pancreatitisen_US
dc.titleReply [2]en_US
dc.typeLetteren_US

Dosyalar